A61P 9 - Drugs for disorders of the cardiovascular system

Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
11/1992
11/25/1992	EP0515265A1 Pyrimidin derivates, process for their preparation, the obtained intermediates, their use as medicines and the pharmaceutical compositions containing them
11/25/1992	EP0515108A2 Azolo (1,3,5) triazines as adenosine antagonists
11/25/1992	EP0515107A2 Azolo (1,3,5) triazines as adenosine antagonists
11/25/1992	EP0514942A1 Novel benzopyran derivatives and processes for the preparation thereof
11/25/1992	EP0514851A1 N-acyl-tetrahydroisoquinolines as inhibitors of acyl-coenzyme a:cholesterol acyl transferase
11/25/1992	EP0514814A1 Diltiazem formulation
11/25/1992	EP0514721A1 Peptides having thrombospondin-like activity and their therapeutic use
11/25/1992	EP0514667A1 Benzazepin derivatives as vasopressin antagonists
11/25/1992	EP0514452A1 Use of insulin sensitizing agents to treat hypertension.
11/25/1992	EP0514419A1 Thioformamide derivatives
11/25/1992	CN1019194B Preparation of bicyclic sulfonamide
11/24/1992	US5166377 Thromboxane A2 antagonist as coagulants or vasoconstrictors
11/24/1992	US5166347 Hypotensive agents, cardiovascular disorders, antiischemic agents and anticoagulants
11/24/1992	US5166328 Antiischemic agents and nervous system disorders
11/24/1992	US5166316 Polypeptides for genetic engineering
11/24/1992	US5166213 4-pyridyl substituted-1,3-dioxane compounds
11/24/1992	US5166188 Butenoic acid derivatives
11/24/1992	US5166166 3-dicyclohexylaminosydnone imines, process for their preparation and their use
11/24/1992	US5166137 Guluronic acid polymers and use of same for inhibition of cytokine production
11/24/1992	CA2069455A1 Azole derivatives
11/24/1992	CA2069261A1 Pyrimidine derivatives, their preparation process, the new intermediates obtaines, their application as drugs and the pharmaceutical compositions containing them
11/24/1992	CA2068747A1 Heterocyclic compounds
11/24/1992	CA1310794C Derivatives of bicyclic amino acids, a process for their preparation, agents containing them and their use
11/24/1992	CA1310793C Nor-statine and nor-cyclostatine polypeptides
11/24/1992	CA1310646C Antiarrhythmic agents
11/24/1992	CA1310642C 2-amino-5-hydroxy-4-pyrimidones
11/23/1992	WO1992020346A1 Method and composition to reduce myocardial reperfusion injury
11/23/1992	CA2063055A1 Peptides having thrombospondin-like activity and their therapeutic use
11/22/1992	CA2068918A1 Formulations useful for the inhibition of massive release of cerebral glutamate
11/21/1992	CA2068980A1 Diltiazem formulation
11/19/1992	EP0514367A2 Protein C-containing drug
11/19/1992	EP0514276A1 Thiopyranopyrrole derivatives and their preparation
11/19/1992	EP0514275A1 Thiopyranopyrrole derivatives, their preparation and pharmaceutical compositions containing them
11/19/1992	EP0514217A1 Antihypertensive benzofuran derivatives carrying 4-pyrazolylmethyl substituents
11/19/1992	EP0514216A1 Antihypotensive benzofuran derivatives with N-linked 1H-imidazolyl-methyl-5-carboxamide substituents
11/19/1992	EP0514198A1 1H-Imidazol-1-yl-methyl benzofuran derivatives with the imidazolyl moiety being substituted by a cycloalkyl group
11/19/1992	EP0514197A1 Anti-hypertensive benzofuran derivatives substituted by N-imidazolyl-methyl groups which are condensed with optionally nitrogen containing, six-membered rings
11/19/1992	EP0514193A1 N-linked imidazolyl-methyl benzofuran derivatives with antihypotensive activity
11/19/1992	EP0514192A1 Antihypertensive benzofuran derivatives, substituted by varied N-pyrimidinyl- or N-imidazolyl-methyl groups
11/19/1992	EP0514124A2 Use of phosphonomethylphosphinate squalene synthetase inhibitors for the manufacture of a medicament for the lowering cholesterol
11/19/1992	EP0513997A1 Antithrombotic compositions
11/19/1992	EP0513979A1 Angiotensin II antagonists incorporating a substituted thiophene or furan
11/19/1992	EP0513832A1 Use of dibutyl adipate and isopropyl myristate in topical and transdermal products
11/19/1992	EP0513761A2 Bisphosphonate squalene synthetase inhibitors
11/19/1992	EP0513760A2 Use of biphosphonate squalene synthetase inhibitors in pharmaceutical compositions useful in lowering cholesterol
11/19/1992	EP0513533A2 Heterocyclic substituted phenylacetic-acid derivatives, process for their preparation and their pharmaceutical application
11/19/1992	EP0513387A1 Active oxygen inhibitor
11/19/1992	EP0513058A1 Use of known uraciles for the manufacture of a medicament for the protection from and treatment of diseases involving proliferative processes.
11/19/1992	EP0513016A1 Cycloalkyl-substituted glutaramide diuretic agents
11/18/1992	WO1992020686A1 Novel derivatives of thiopyranopyrrole and preparation thereof
11/18/1992	WO1992020685A1 Novel derivatives of thiopyranopyrrole, their preparation and pharmaceutical compositions containing them
11/18/1992	WO1992020648A1 Ocular hypotensive 2-decarboxyl-2-acylthioalkyl prostaglandin derivatives
11/18/1992	CN1066272A Process for preparation of anti-thrombin polypeptides
11/18/1992	CN1066184A Optimized tablet formulation
11/18/1992	CN1019116B Cardiotonic tricyclic oxazolones and the prepn. therefor
11/18/1992	CA2109296A1 New thiopyranopyrrole derivatives; process for preparing the same and pharmaceutical compositions containing them
11/18/1992	CA2109295A1 New thiopyranopyrrole derivatives and process for preparing them
11/18/1992	CA2102295A1 Ocular hypotensive 2-decarboxyl-2-acylthioalkyl prostaglandin derivatives
11/17/1992	US5164509 Benzodiazolo analogs
11/17/1992	US5164489 Protein growth factor useful in diagnosis and treatment of lung cancer
11/17/1992	US5164407 Substituted imidazo-fused 5-membered ring heterocycles and their use as angiotensin ii antagonsists
11/17/1992	US5164404 Amino acid antagonists
11/17/1992	US5164401 Method of diuretic treatment with 3,7-diazabicyclo[3,3,1]nonane compounds
11/17/1992	US5164397 Hypotensive
11/17/1992	US5164378 Supersulfated heparins
11/17/1992	US5164296 Cardiovascular, renal
11/17/1992	CA2068779A1 Benzofuran derivatives
11/17/1992	CA2068766A1 Benzofuran derivatives
11/17/1992	CA2068756A1 Benzofuran derivatives
11/17/1992	CA1310331C SUBSTITUTED .alpha.-AMINO ACIDS, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
11/17/1992	CA1310317C Prodrugs of antihypercholesterolemic compounds
11/14/1992	CA2068550A1 Method for lowering cholesterol employing bisphosphonate squalene synthetase inhibitors
11/14/1992	CA2067974A1 Method for lowering cholesterol employing a phosphonomethylphosphinate squalene synthetase inhibitor
11/14/1992	CA2067967A1 Bisphosphonate squalene synthetase inhibitors and method
11/12/1992	WO1992020671A1 NOVEL 2H-BENZO[b]PYRANE DERIVATIVES SUBSTITUTED IN THE 4 POSITION BY ARYL OR N-HETEROARYL, PROCESS FOR PRODUCING THEM AND PREPARATIONS CONTAINING THE COMPOUNDS
11/12/1992	WO1992019748A1 Herpesvirus particles and vaccine
11/12/1992	WO1992019736A1 Growth hormone antagonists
11/12/1992	WO1992019644A1 Vasorelaxant peptide
11/12/1992	WO1992019617A2 Substituted dibenzoxazepine compounds, pharmaceutical compositions and methods of use
11/12/1992	WO1992019614A1 4-aryl-3-(heteroarylureido)quinoline derivatives
11/12/1992	WO1992019613A2 1,2-dithiole-3-thione derivative-based therapeutical compositions
11/12/1992	WO1992019249A1 Compositions for the prevention and/or treatment of pathological processes
11/12/1992	WO1992019243A1 Liposomal prostaglandin formulations
11/12/1992	WO1992019228A1 Optimized tablet formulation
11/12/1992	DE4115465A1 Neue in 4-stellung durch aryl oder n-heteroaryl substituierte 2h-benzo(b)pyran-derivate, verfahren zu ihrer herstellung und ihre verwendung sowie die verbindungen enthaltende zubereitungen New in the 4-position by aryl or heteroaryl substituted n-2h-benzo (b) pyran derivatives, process for their production and their use as well as the compounds containing preparations
11/12/1992	CA2102904A1 Novel 2h-benzo[b]pyrane derivatives substituted in the 4 position by aryl or n-heteroaryl, process for producing them and preparations containing the compounds
11/12/1992	CA2102207A1 Compositions for the prevention and/or treatment of patholigical processes
11/11/1992	WO1992020662A1 Acidic aralkyl triazole derivatives active as angiotensin ii antagonists
11/11/1992	WO1992020660A1 Substituted 1-(2h)-isoquinolinones bearing acidic functional groups as angiotensin ii antagonists
11/11/1992	EP0512916A2 Liposomal prostaglandin formulations
11/11/1992	EP0512901A1 Aminated polycyclic compounds and their enantiomers, process for their preparation and pharmaceutical compositions containing them
11/11/1992	EP0512899A1 Benzopyran compounds, process for their preparation and pharmaceutical compositions containing them
11/11/1992	EP0512870A1 Substituted quinazolinones bearing acidic functional groups as angiotensin II antagonists
11/11/1992	EP0512817A1 Pyridazinedione derivatives, their preparation and pharmaceutical applications
11/11/1992	EP0512755A2 Piperazine derivatives
11/11/1992	EP0512733A2 Modified complement system regulator
11/11/1992	EP0512676A1 Angiotensin II antagonists incorporating a substituted benzyl element
11/11/1992	EP0512675A1 Angiotensin II antagonists incorporating a substituted thiophene or furan
11/11/1992	EP0512570A1 Urea derivatives, processes for the preparation thereof and pharmaceutical composition comprising the same
11/11/1992	EP0512400A1 Substituted dibenzoxazepine compounds, pharmaceutical compositions and methods of use

1 ... 1472 1473 1474 1475 1476 1477 1478 1479 1480 1481 1482 1483 1484 1485 1486 1487 1488 1489 1490 1491 1492 ... 1595